"It's going to turn around and bind to other RNAs, physically bind to them, in a way that will then determine whether those other RNAs get made into protein or not."
VOA: standard.2010.04.05
The toxin attacks a protein that helps bind skin cells together.
The model also suggested that an anti-inflammatory drug called celecoxib should bind with CDH11, a protein which plays an important role in the development of both rheumatoid arthritis and metastatic breast cancer.